The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1974, 113: 1694-1702.
Copyright © 1974 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dvorak, H. F.
Right arrow Articles by Rypysc, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dvorak, H. F.
Right arrow Articles by Rypysc, J.

Purification of Basophilic Leukocytes from Guinea Pig Blood and Bone Marrow1

Harold F. Dvorak2, Salvatore S. Selvaggio, Ann M. Dvorak, Robert B. Colvin, Deborah B. Lean and Jane Rypysc

From the Departments of Pathology, Massachusetts General Hospital and Harvard Medical School and Tufts University Medical School, Boston, Massachusetts 02114

Abstract

Methods are presented for obtaining highly purified preparations of basophilic leukocytes from the blood (mean purity, 62%) and bone marrow (mean purity, 38%) of guinea pigs. The following steps are performed in sequence: harvest of blood or bone marrow cells from animals primed with antigen to develop a basophilia; phagocytosis of carbonyl iron particles by neutrophils and monocytes; sedimentation of erythrocytes with gelatin (in the case of peripheral blood); removal of phagocytic cells and residual-free iron particles by passage through a magnetic field; centrifugation on a newly developed 4.5 to 9.5% linear Ficoll density gradient; and removal of residual erythrocytes by Tris-NH4Cl (optional step for peripheral blood). The basophils isolated are viable, functional cells, and, depending on the source and degree of purity desired, may be obtained in quantities of 5 x 106 to 2 x 108 and in an overall yield of 25 to 100%.

Footnotes

1 This work was supported by United States Public Health Service Grants AI-09529 and CA-15136 and by American Cancer Society Grant IM-44.

2 H. F. D. is United States Public Health Service Research Career Development Awardee 1-K-04-AI-46352.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.